Using Diffuse Reflectance Spectroscopy to Classify Tumor Tissue in Upper Gastrointestinal Cancers—Reply
- 1 July 2023
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Surgery
- Vol. 158 (7) , 773
Abstract
In Reply We would like to thank Liu and Yang for their interest in our article1 and for taking the time to express their points for discussion. We appreciate the opportunity to respond. Liu and Yang inquire as to whether the specimens in patients who had undergone neoadjuvant treatment were significantly different in their optical properties to those who had not. At this stage, we have not yet explored the wavelength characteristics when using diffuse reflectance spectroscopy (DRS) on treatment-naive specimens vs those having undergone neoadjuvant treatment. The use of neoadjuvant therapy leads to the formation of scar tissue over healthy areas surrounding the tumor,2,3 and therefore further evaluation of these patients in future studies will aid in classifying fibrosed tissue and improve the accuracy of margin assessment.Keywords
This publication has 3 references indexed in Scilit:
- Real-time Tracking and Classification of Tumor and Nontumor Tissue in Upper Gastrointestinal Cancers Using Diffuse Reflectance Spectroscopy for Resection Margin AssessmentJAMA Surgery, 2022
- Rectal cancer staging: focus on the prognostic significance of the findings described by high-resolution magnetic resonance imagingCancer Imaging, 2013
- Rectal Cancer: Primary Staging and Assessment After ChemoradiotherapySeminars in Radiation Oncology, 2011